mortality/aging
• premature death, with a median lifespan of 30 weeks compared to 123 weeks in controls
|
growth/size/body
• mice develop body weight reduction after the 4th month of life
|
adipose tissue
• mice show a reduction in brown adipose tissue after the 4th month of life
|
• mice show a reduction in white adipose tissue after the 4th month of life
|
• mice exhibit smaller adipocytes
|
behavior/neurological
• mice exhibit abnormal posture characterized by a hunched position
|
cardiovascular system
• mice develop hypertrophy of small pulmonary arteries with thickening of the tunica media
|
• aortas exhibit higher amount of elastic fibers indicating aortic fibrosis
|
• fibrotic accumulation in the tunica adventitia
|
• medial thickening in the vessel wall of the aorta
|
• necrotic areas with collagen accumulation are seen in hearts
|
hypertension
(
J:267719
)
• mice develop systemic hypertension, showing higher levels of systemic blood pressure
|
cellular
• increase in cardiac mitochondrial DNA
|
• cardiac mitochondrial size is smaller, with an accumulation of smaller rounded mitochondria in cardiomyocytes
|
• increase in the number of mitochondria in hearts
|
homeostasis/metabolism
• serum creatinine level is lower
• however, the kidneys do not show any morphological alteration
|
• 3 month old mice administered angiotensin II develop more large fibrotic lesions than controls
• 3 month old mice show higher susceptibility to angiotensin II-induced cardiac heart failure, as 40% of mice die during treatment
|
renal/urinary system
• severe bladder distension
|
• the growing pressure inside the bladder is accompanied by urothelium and muscular layer atrophy
|
reproductive system
infertility
(
J:267719
)
skeleton
vision/eye